Feedback / Questions
Keytruda (pembrolizumab) - Merck (MSD)
Temodex (temozolomide gel) - Belmedpreparaty, Double Bond Pharmaceutical
https://www.businesswire.com/news/home/20220324005952/en/Updated-2-THE-TOP-Data-Suggest-Improvements-in-Progression-Free-Survival-Overall-Survival-Compared-to-Matched-Control-Patients-from-EF-14-Trial
Mar 24, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next